Cartilage oligomeric matrix protein is an endogenous β-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury

Yi Fu,Yaqian Huang,Zhao Yang,Yufei Chen,Jingang Zheng,Chenfeng Mao,Zhiqing Li,Zhixin Liu,Bing Yu,Tuoyi Li,Meili Wang,Chanjuan Xu,Yiwei Zhou,Guizhen Zhao,Yiting Jia,Wei Guo,Xin Jia,Tao Zhang,Li Li,Ziyi Liu,Shengchao Guo,Mingliang Ma,Heng Zhang,Bo Liu,Junbao Du,Wengong Wang,Chaoshu Tang,Pei Gao,Qingbo Xu,Xian Wang,Jianfeng Liu,Jinpeng Sun,Wei Kong
DOI: https://doi.org/10.1038/s41422-020-00464-8
IF: 44.1
2021-01-28
Cell Research
Abstract:Abstract Compelling evidence has revealed that biased activation of G protein-coupled receptor (GPCR) signaling, including angiotensin II (AngII) receptor type 1 (AT1) signaling, plays pivotal roles in vascular homeostasis and injury, but whether a clinically relevant endogenous biased antagonism of AT1 signaling exists under physiological and pathophysiological conditions has not been clearly elucidated. Here, we show that an extracellular matrix protein, cartilage oligomeric matrix protein (COMP), acts as an endogenous allosteric biased modulator of the AT1 receptor and its deficiency is clinically associated with abdominal aortic aneurysm (AAA) development. COMP directly interacts with the extracellular N-terminus of the AT1 via its EGF domain and inhibits AT1-β-arrestin-2 signaling, but not Gq or Gi signaling, in a selective manner through allosteric regulation of AT1 intracellular conformational states. COMP deficiency results in activation of AT1a-β-arrestin-2 signaling and subsequent exclusive AAA formation in response to AngII infusion. AAAs in COMP –/– or ApoE –/– mice are rescued by AT1a or β-arrestin-2 deficiency, or the application of a peptidomimetic mimicking the AT1-binding motif of COMP. Explorations of the endogenous biased antagonism of AT1 receptor or other GPCRs may reveal novel therapeutic strategies for cardiovascular diseases.
cell biology
What problem does this paper attempt to address?
The paper aims to explore the role of Cartilage Oligomeric Matrix Protein (COMP) in vascular homeostasis and injury, and to reveal its mechanism of influence on the Angiotensin II (AngII) Type 1 Receptor (AT1 receptor) signaling pathway. Specifically, the paper attempts to answer the following key questions: 1. **The relationship between COMP and Abdominal Aortic Aneurysm (AAA)**: The study found that the expression of COMP is significantly reduced in both human and mouse AAA patients. This suggests that COMP may play a protective role in the occurrence and development of AAA. 2. **How COMP regulates the AT1 receptor**: COMP selectively inhibits the β-arrestin-2 signaling pathway by directly interacting with the N-terminus of the AT1 receptor, without affecting the Gq or Gi signaling pathways. This regulation is achieved by altering the intracellular conformational state of the AT1 receptor. 3. **Consequences of COMP deficiency**: COMP gene knockout leads to a higher susceptibility of mice to form AAA under AngII stimulation. Additionally, supplementing COMP can reverse this effect, further demonstrating the importance of COMP in preventing AAA. 4. **Mechanism of action of the AT1 receptor**: The study shows that the AT1a receptor mediates the formation of AAA caused by COMP deficiency. If the AT1a receptor is simultaneously knocked out, it can rescue the AAA phenotype induced by COMP deficiency. In summary, the paper primarily investigates the role of COMP as an endogenous biased regulator in the AT1 receptor signaling pathway and its relationship with cardiovascular diseases, particularly AAA. This discovery provides new potential strategies for the treatment of cardiovascular diseases in the future.